3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
15
Prostatic Neoplasms
9
Colorectal Neoplasms
7
Ovarian Neoplasms
5
Endometrial Neoplasms
5
Colonic Neoplasms
5
Rectal Neoplasms
4
Colorectal Neoplasms, Hereditary Nonpolyposis
4
Pancreatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Brain Neoplasms
3
Urogenital Neoplasms
2
Neoplastic Syndromes, Hereditary
2
Neoplasms, Unknown Primary
2
Neoplasm Metastasis
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Leukemia, Eosinophilic, Acute
2
Leukemia, Basophilic, Acute
2
Leukemia
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Hematologic Neoplasms
2
Glioma
2
Carcinoma, Intraductal, Noninfiltrating
2
Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8
1
Tuberous Sclerosis
1
Thyroid Neoplasms
1
Spinal Cord Neoplasms
1
Interventions
Radiosurgery
79
Capecitabine
77
Oxaliplatin
74
Fluorouracil
69
Bevacizumab
69
Gemcitabine
67
Leucovorin
61
pembrolizumab
53
Nivolumab
53
Paclitaxel
48
Irinotecan
47
Radiotherapy
45
Cisplatin
44
Everolimus
38
Magnetic Resonance Spectroscopy
36
Drug Therapy
36
Docetaxel
36
Cyclophosphamide
35
Cetuximab
35
Ipilimumab
32
Carboplatin
32
Trastuzumab
31
Sunitinib
30
Sorafenib
26
Erlotinib Hydrochloride
25
Doxorubicin
23
Surveys and Questionnaires
20
Surgical Procedures, Operative
20
Specimen Handling
20
Biopsy
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasm Metastasis
×
Genetic Testing
×
Clear all
NCT03503097
2025-10-01
GENTleMEN
University of Washington
Terminated
799 enrolled
NCT01460186
2019-01-15
StoRM
Centre Leon Berard
Phase NA
Completed
1,000 enrolled